Neoadjuvant Chemotherapy with Sequential Methotrexate and 5-Fluorouracil Scheduling, Epirubicin and Cisplatin for Locally Advanced Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0232|63|1|1-5

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.1, 2002-08, pp. : 1-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy with Cyclophosphamide, Mitoxantrone, and 5-Fluorouracil in Locally Advanced Breast Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 2, 2005-01 ,pp. : 81-85

Karger

Access to resources Recommend Favorite

Phase 1/2 Study of Synchronous Methotrexate, Cisplatin, Vincristine (MOPq10) Chemotherapy and Radiation for Patients with Locally Advanced Bladder Cancer

By  

Urologia Internationalis, Vol. 67, Iss. 4, 2001-12 ,pp. : 293-297

Karger

Access to resources Recommend Favorite

Prospective Phase II Study of Neoadjuvant Therapy with Cisplatin, 5-Fluorouracil, and Bevacizumab for Locally Advanced Resectable Esophageal Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 427-431

Karger

Access to resources Recommend Favorite

Clinical Pilot Study of Intrahepatic Arterial Chemotherapy with Methotrexate, 5-Fluorouracil, Cisplatin and Subcutaneous Interferon-Alpha-2b for Patients with Locally Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 39-47

Karger

Access to resources Recommend Favorite